Anthony Saleh

Anthony Saleh has a diverse work experience that spans multiple industries and roles. In 2008, they worked as a CRTA Postdoctoral Fellow at the National Cancer Institute. From 2011 to 2014, they were a Postdoctoral Fellow at the National Institutes of Health, specifically in the Tumor Biology Section of the NIDCD. Anthony then joined the National Institutes of Health as a Scientist in the Tumor Biology Section from 2014 to 2016. During this time, Saleh served as an Entrepreneur in Residence at BioHealth Innovation, Inc. from 2014 to 2020. In 2015, they took on the role of President MIMETAS US and Director of Product R&D at MIMETAS - The Organ on a Chip Company, a position they held until 2019. Currently, Saleh is the Co-founder and CEO of miRecule, Inc., a role they have held since 2018.

Anthony Saleh earned a Ph.D in Biochemistry and Molecular Biology from Johns Hopkins University, Bloomberg School of Public Health, which they attended from 2002 to 2008. Prior to that, they obtained a B.S. Honors degree in Biochemistry from St Bonaventure University, where they studied from 1997 to 2001.